In the present study, we identified five novel autoantibodies with possible diagnostic value in ACPA‐negative RA (anti‐ANAPC15, anti‐LSP1, anti‐APBB1, anti‐PTMS, and anti‐UBL7), especially in the early stage. The gene discussed is PRTN3; the disease is rheumatoid arthritis.